Tawfeq Bin Omran

Dr. Ben-Omran received his speciality training in clinical and metabolic genetics at the Hospital for Sick Children, University of Toronto, Canada. He is a fellow of both Royal College of Physicians and Surgeons of Canada (FRCPS) and Canadian College of Medical Genetics (FCCMG). He is also fellow of American College of Medical Genetics and Genomics (FACMG).

Currently, he is a senior consultant and Head of Clinical and Metabolic Genetics at Hamad Medical Corporation. He is an Associate Professor at Weill Cornell Medical College, Qatar and New York-USA. He is also a Distinguished Visiting Scientist at Boston Children’s Hospital-USA. He contributes to the body of published knowledge in clinical and metabolic genetics, with over 60 published articles in peer reviewed journals, book chapters and abstracts. He is reviewer for many clinical genetics journals.

He is an active clinical researcher, collaborating on projects with local, regional and international communities. He is a lead primary investigator in many high profile research projects and clinical trials to evaluate the long-term effects of enzyme replacement therapy in patients with different lysosomal storage disorders. His main scientific interests in phenotypic and molecular delineation of consanguineous population include genetics of brain malformation and microcephaly, white matter disorders and novel therapies for Qatar patients with Homocystinuria. In addition, Dr. Ben-Omran is an external advisor and expert for E-HOD (European registry and network for homocystinurias and methylation defects.